SCHD beat bearish macro trends as ABT, MRK & AMGN surged. Learn why dividend growth makes waiting costly—and what to do now.

Pfizer remains undervalued, demonstrating robust profitability and offering an attractive forward dividend yield above 6%.

Maximizing portfolio yield exposes investors to hidden risks, especially inflation and lack of income growth. Click here to ...

Hyperscalers are set to account for 9% of gross investment-grade bond supply in 2026, according to Bank of America’s global ...

Shares of chip and AI-related companies were largely mixed on Friday, while the broader market was largely among gains.

Treasury doubles debt buybacks, Trump targets Iran sanctions, Citadel buys AI fund, and Bitcoin surges on short squeeze—Read ...

World Liberty Financial investors, incl. Eric Trump, sign OCC “passivity” pledges for a new trust bank charter.

Why higher Fed rates aren’t slowing U.S. growth like past cycles: AI data-center spending, fiscal stimulus and tariffs keep ...

Enterprise Products Partners (EPD) upgraded to Strong Buy: surging Q2 results, attractive valuation and 5.76% yield. Click to ...

Rocket Lab Corporation's outlook shows Space Systems revenue surge and a $2.36B backlog fuels growth. Click for this RKLB ...

Market stability now hinges on Kevin Warsh's and the Fed's willingness to coordinate with Treasury to manage rates and ...

The Magnificent Seven now trade at discounted valuations, offering compelling risk-adjusted return potential as AI CapEx ...